Resideo Technologies, Inc., a leading global provider of home comfort and security solutions, announced the appointment of Kareem Yusuf, Ph.D., as a new member of its Board of Directors. Dr. Yusuf will stand for re-election by shareholders at the 2021 annual meeting.
Dr. Yusuf brings to the Board of Directors more than 17 years of executive leadership experience at IBM leading organizations across a variety of disciplines, including Product Management, Software Development, Mergers & Acquisitions, Technical Sales and Customer Support.
Recommended AI News: GrammaTech Introduces Shift Left Academy
As the current General Manager for AI Applications at IBM, Dr. Yusuf is responsible for a multibillion-dollar P&L focused on providing enterprise applications and industry solutions which harness the power of critical technologies such as AI, IoT, hybrid cloud and blockchain. He has extensive experience in managing and growing market-leading brands and applications, working with thousands of clients from around the globe and regularly consulting with global C-suite and line of business executives to help them amplify and maximize the value of their IBM investments.
“I am excited to join the board of a company whose core business and technologies are essential to so many people around the world,” said Dr. Yusuf. “I look forward to working with the team to help Resideo further drive its transformation initiatives and expand its presence across its current markets and in new technologies.”
Recommended AI News: UST HealthProof and HealthEdge Announce Multiyear Strategic Partnership with Gateway Health
Dr. Yusuf earned his Ph.D. in Civil Engineering from the University of Leeds. He is an accomplished speaker, having presented multiple tech conference keynotes and given a TED Talk.
“Dr. Yusuf is an accomplished global business and technology leader with vast experience across a variety of cutting-edge disciplines,” said Roger Fradin, chairman of the board for Resideo. “His experience will greatly enhance Resideo’s drive to build upon the company’s rich foundation of technology and spur innovation and new product introduction.”
Recommended AI News: Konica Minolta Precision Medicine collaborates with AWS to create the next generation of precision diagnostics
Comments are closed.